Comments

Amicus Therapeutics Stock Guidance

FOLDNASDAQ
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$14.33
0.020.14%
At close: Jan 15, 4:00 PM EST
$14.29
-0.02-0.14%
Pre-Market: 4:41 AM EST
OverviewNewsEarningsOptions

Guidance

Analyst RatingsInsider TradesShort InterestGovernment TradesStock Report

Amicus Therapeutics Stock Guidance | NASDAQ:FOLD | Benzinga

Amicus Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
11/04/2025FOLD
Amicus Therapeutics
FY2025———$607.54M$644.52M$626.04MGet Alert
07/31/2025FOLD
Amicus Therapeutics
FY2025———$607.54M$644.52M$621.32MGet Alert
05/01/2025FOLD
Amicus Therapeutics
FY2025———$607.54M$644.52M$631.23MGet Alert
02/19/2025FOLD
Amicus Therapeutics
FY2025———$618.11M$655.09M$636.01MGet Alert
01/12/2025FOLD
Amicus Therapeutics
Q42024———$149.90M$149.90M$147.53MGet Alert
01/12/2025FOLD
Amicus Therapeutics
FY2024———$528.50M$528.50M$526.12MGet Alert
11/06/2024FOLD
Amicus Therapeutics
FY2024———$519.16M$527.15M$517.07MGet Alert
08/08/2024FOLD
Amicus Therapeutics
FY2024———$503.19M$523.16M$510.32MGet Alert
05/09/2024FOLD
Amicus Therapeutics
FY2024———$499.19M$519.16M$529.99MGet Alert
01/07/2024FOLD
Amicus Therapeutics
FY2023———$399.40M$399.40M$396.45MGet Alert
01/09/2023FOLD
Amicus Therapeutics
FY2022———$329.00M$329.00M$326.68MGet Alert
08/04/2022FOLD
Amicus Therapeutics
FY2022———$350.00M$365.00M$355.01MGet Alert
05/09/2022FOLD
Amicus Therapeutics
FY2022———$350.00M$365.00M$363.85MGet Alert
02/24/2022FOLD
Amicus Therapeutics
FY2022———$350.00M$365.00M$375.35MGet Alert

FAQ

Q

What is the most recent guidance for Amicus Therapeutics (FOLD)?

A

There have been no specific sales or earnings guidance reported for Amicus Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

Immunovant Inc
NASDAQ:IMVT
$25.29
-3.88%
IDEAYA Biosciences Inc
NASDAQ:IDYA
$35.43
-1.16%
Legend Biotech Corp
NASDAQ:LEGN
$21.87
-1.23%
Celcuity Inc
NASDAQ:CELC
$106.01
-0.90%
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
$22.15
-0.23%
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
$26.30
1.71%
Alkermes PLC
NASDAQ:ALKS
$31.33
-0.96%
Protagonist Therapeutics Inc
NASDAQ:PTGX
$82.26
0.33%
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved